Pacific Biosciences Of California (PACB) Net Margin Growth (5y) (2015 - 2026)
Pacific Biosciences Of California (PACB) Net Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Pacific Biosciences Of California | 428.15 Mn | 152.18 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,891.00 |
| Dec 31, 2025 | -36,657.00 |
| Sep 30, 2025 | 2,539.00 |
| Jun 30, 2025 | 36,989.00 |
| Mar 31, 2025 | -93,114.00 |
| Dec 31, 2024 | 7,555.00 |
| Sep 30, 2024 | -2,062.00 |
| Jun 30, 2024 | -37,963.00 |
| Mar 31, 2024 | -701.00 |
| Dec 31, 2023 | 1,950.00 |
| Sep 30, 2023 | 23,176.00 |
| Jun 30, 2023 | -1,132.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | -22,367.00 |
| Sep 30, 2022 | -11,664.00 |
| Jun 30, 2022 | -4,358.00 |
| Mar 31, 2022 | 3,531.00 |
| Dec 31, 2021 | -11,973.00 |
| Jun 30, 2021 | -19,717.00 |
| Mar 31, 2021 | -3,004.00 |